| Market cap | Sales (TTM) | Net profit (TTM) | P/E | EPS (TTM) | P/B | ROE | ROE previous year | ROCE | Debt / equity | Free cash flow | EV / EBITDA | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹507 cr | ₹545 cr | ₹32 cr | 16.1 | 5.31 | 1.97 | 13.3% | 17.3% | 20.7% | 0.02 | ₹0 cr | 8.0 | 1.17 |
| Quarter | Sales ₹ cr | Net profit ₹ cr | EPS | EPS YoY | Sales YoY | Net margin |
|---|---|---|---|---|---|---|
| Jun 2026 | 139 | 6 | 0.98 | -17.0% | +1.4% | 4.3% |
| Mar 2026 | 138 | 10 | 1.76 | -14.1% | -10.6% | 7.6% |
| Dec 2025 | 129 | 7 | 1.15 | -21.8% | +5.8% | 5.3% |
| Sep 2025 | 139 | 8 | 1.42 | -3.9% | +1.3% | 6.1% |
| Jun 2025 | 137 | 7 | 1.18 | -16.8% | +5.3% | 5.2% |
| Mar 2025 | 154 | 12 | 2.05 | +5.5% | +9.3% | 7.7% |
| Dec 2024 | 122 | 9 | 1.47 | +15.5% | -1.5% | 7.1% |
| Sep 2024 | 137 | 9 | 1.48 | — | — | 6.4% |
| Check | Result |
|---|---|
| Latest quarter EPS up 25%+ on a year ago | ✗ Fail |
| EPS growth accelerating over 3 quarters | ✗ Fail |
| Sales up 25%+, or sales growth accelerating | ✗ Fail |
| Annual EPS up 25%+ in each of the last 2 years | — Not assessable |
| Net margin above the same quarter last year | ✗ Fail |
| Method | Checks | Score | Verdict |
|---|---|---|---|
| Minervini | ✗ Close above the 150- and 200-day averages ✗ 150-day above 200-day ✗ 200-day rising for a month ✗ 50-day above the 150- and 200-day ✗ Close above the 50-day ✗ At least 25% above the 52-week low · low 81.54 ✗ Within 25% of the 52-week high · high 130.64 ✗ RS percentile 70 or more · RS 16 Minervini's trend template - the gate the scanner applies. | 0/8 | 0 of 8 |
| Weinstein | Stan Weinstein's stage analysis on the 30-week moving average. | Stage 4 - declining | |
| CAN SLIM | ✗ C latest quarter EPS up 25%+ — A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✗ N within 15% of the 52-week high · high 130.64 ✗ S more volume on up days than down days (50 sessions) · 0.49x ✗ L RS percentile 80 or more · RS 16 — I institutional sponsorship rising (FII + DII) · not yet collected for this stock ✗ M market in an uptrend (40%+ of stocks above their 200-day) · breadth 39% William O'Neil's growth-leader checklist. | 0/5 | Weak |
| Darvas | ✗ New 52-week high in the last 120 sessions Darvas needs a new 52-week high to start a box. | 10/100 | No box |
| Turtle | ✗ Close above the prior 55-session high · 104.90 ✗ Close above the prior 20-session high · 96.00 ✗ Close below the prior 20-session low · 80.01 Donchian channel breakout - the Turtle traders' entry. | No signal | |
| Greenblatt | — Earnings yield (EBITDA / EV) · 12.5% — Return on capital (ROCE) · 20.7% Joel Greenblatt's Magic Formula: good businesses at good prices, ranked across all companies. Earnings yield uses EBITDA, as EBIT is not held separately. | 91/100 | Strong |
| Graham | ✗ Price at or below the Graham number · Graham number 72.03 ✗ P/E 15 or less · P/E 16.1 ✗ P/B 1.5 or less (or P/E x P/B 22.5 or less) · P/B 1.97 ✓ Current ratio 2 or more · 2.50 — 10 years of positive earnings, 20 of dividends · history not held Benjamin Graham's defensive-investor tests. | 84/100 | Fair |
| Piotroski | ✓ Profitable (ROA > 0) ✓ Operating cash flow positive ✗ ROA rising ✓ Cash flow above net profit (earnings quality) ✓ Long-term debt / assets falling ✓ Current ratio rising · 2.50 ✓ No new shares issued ✗ Margin rising (net margin) ✗ Asset turnover rising Joseph Piotroski's F-score, FY 2025 -> 2026. | 6/9 | Average |
| Stock | 1M % | 3M % | 6M % | 1Y % | 3Y % | 5Y % | P/E | P/B | ROE % | ROCE % | ROA % | D/E | EV/EBITDA | ₹ Cr | Sales TTM ₹ Cr | Profit TTM ₹ Cr | EPS | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LINC this stock | -6.6 | -18.9 | -13.3 | -34.5 | -58.6 | — | 16.1 | 1.97 | 13.3 | 20.7 | — | 0.02 | 8.0 | 507 | 545 | 32 | 5.3 | 1.17 |
| NOVARTIND | -11.8 | +4.0 | +78.6 | +163.0 | +151.7 | +127.7 | 47.5 | 5.34 | 12.0 | — | — | — | — | 4,377 | — | — | 39.6 | — |
| SCPL | -12.2 | -1.6 | +88.0 | +148.0 | +29.5 | — | 29.0 | 3.84 | 13.2 | — | — | 0.32 | 16.3 | 602 | 386 | 21 | 19.8 | 0.53 |
| PREMIERPOL | +23.2 | +22.9 | +74.8 | +121.9 | +253.7 | +626.9 | 27.8 | 6.17 | 24.1 | 32.9 | — | 0.00 | 23.1 | 1,035 | 396 | 37 | 3.5 | 0.62 |
| CALSOFT | -26.1 | +36.8 | +147.1 | +71.7 | +118.1 | -13.1 | 12.8 | 4.55 | 32.3 | 42.0 | — | 0.04 | — | — | 25 | 15 | 2.4 | 0.59 |
| VALIANTLAB | +5.2 | +113.0 | +98.1 | +61.3 | -29.3 | — | 45.3 | 2.34 | -1.2 | 0.8 | — | 0.14 | 92.5 | 726 | 306 | 16 | 3.0 | 0.81 |
| KENNAMET | -12.1 | +39.0 | +51.3 | +54.4 | +50.1 | +177.1 | 46.2 | 9.84 | 23.0 | — | — | — | — | 8,404 | — | — | 89.2 | — |
| AKSHARCHEM | -4.0 | +67.7 | +92.9 | +50.9 | +42.7 | -23.1 | 22.5 | 1.21 | -0.2 | 0.7 | — | 0.41 | 23.4 | 316 | 416 | 14 | 17.5 | 0.81 |
| CHEMBONDCH | -10.8 | -9.5 | +53.2 | +44.3 | — | — | 16.5 | 3.03 | 18.5 | — | — | 0.00 | 11.6 | 627 | 347 | 38 | 14.2 | 1.27 |
| MARALOVER | +3.6 | +7.2 | +31.5 | +29.6 | -15.9 | -23.3 | — | 2.21 | — | — | — | — | — | — | — | — | — | 1.02 |
| IVP | -10.8 | +27.2 | +38.2 | +23.9 | +16.8 | +75.8 | 6.5 | 1.31 | 12.6 | 13.9 | — | 0.42 | 7.3 | 206 | 611 | 32 | 30.5 | 1.06 |
← All NSE stocks · More Other stocks